# Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

> **NCT00195715** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 777 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Adalimumab

## Key facts

- **NCT ID:** NCT00195715
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-03
- **Final completion:** 2008-12
- **Target enrollment:** 777 (ACTUAL)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195715, "Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00195715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*